VRK1 and leukemia: Posttranslational modification, such as phosphorylation, significantly influence HMGA2's biological functions,[29, 41] and HMGA2 SUMOylation may promote promyelocytic leukemia protein degradation.[42] We observed that HMGA2pS105 levels correlated with NOF activation and VRK1 likely acted as a specific kinase.